KEERTAN REDDY: Open Payments
NPI 1114411105 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,458 in 61 payments from 15 companies in 2025. Trend: 2023 $99 · 2024 $193 · 2025 $1,458
Food & beverage: $1,458
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 13 | $361 |
| ABBVIE INC. | 10 | $243 |
| Otsuka America Pharmaceutical, Inc. | 9 | $172 |
| Alkermes, Inc. | 6 | $128 |
| Janssen Scientific Affairs, LLC | 1 | $128 |
| E.R. Squibb & Sons, L.L.C. | 4 | $102 |
| Janssen Pharmaceuticals, Inc | 5 | $92 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $49 |
| Lundbeck LLC | 2 | $38 |
Products named: INGREZZA, VRAYLAR, REXULTI, INVEGA SUSTENNA, ARISTADA, COBENFY, SPRAVATO, TRINTELLIX.
Industry payments across NC — which companies pay providers there.
